While GLP-1s such as tirzepatide, semaglutide, and dulaglutide are known to reduce cardiovascular and all-cause mortality in patients with type 2 diabetes, their effects in patients who also have OSA remain unclear
Monlunabant: Effective but with Side Effects Monlunabant, a weight loss drug used for chronic weight management and metabolic disorders, has shown promising results in clinical trials but comes with notable side effects
This may influence several physiological functions including, but not restricted to, increasing tubuloglomerular feedback and reducing intraglomerular pressure, lowering both pre- and afterload of the heart and downregulating sympathetic activity
Ozempic and Wegovy are the same active ingredient (semaglutide), at different doses for different indications
Deciphering the quenching mechanism of 2D MnO 2 nanosheets towards Au nanocluster fluorescence to design effective glutathione biosensors
Is it better to taper off semaglutide gradually or stop abruptly
